Cecelia A. Laurie

Cecelia A. Laurie

Auto-generated profile, based on publicly available information

Cecelia A. Laurie

Department of Biostatistics, University of Washington, Seattle, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Nature Genetics
Verified
Journal Article
Open access
JHJeroen R. Huyghe
Jeroen R. Huyghe
SBStephanie A. Bien
Stephanie A. Bien
THTabitha A. Harrison
Tabitha A. Harrison
HKHyun Min Kang
Hyun Min Kang
SCSai Chen
Sai Chen
UPUlrike Peters
Ulrike Peters
To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls. Findings were followed up in an additional 23,262 cases and 38,296 controls. We discovered a strongly protective 0.3% frequency variant signal at CHD1. In a combined meta-analysis of 125,478 individuals, we identified 40 new independent signals at P < 5 × 10-8, bringing the number of known independent signals for CRC to ~100. New signals implicate lower-frequency variants, Krüppel-like factors, Hedgehog signaling, Hippo-YAP signaling, long noncoding RNAs and somatic drivers, and support a role for immune function. Heritability analyses suggest that CRC risk is highly polygenic, and larger, more comprehensive studies enabling rare variant analysis will improve understanding of biology underlying this risk and influence personalized screening strategies and drug development.

7 March 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PWPierrick Wainschtein
Pierrick Wainschtein
DJDeepti Jain
Deepti Jain
ZZZhili Zheng
Zhili Zheng
LCL. Adrienne Cupples
L. Adrienne Cupples
ASAladdin H. Shadyab
Aladdin H. Shadyab
PVPeter M. Visscher
Peter M. Visscher

1 January 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MCMatthew P. Conomos
Matthew P. Conomos
CLCecelia A. Laurie
Cecelia A. Laurie
ASAdrienne M. Stilp
Adrienne M. Stilp
SGStephanie M. Gogarten
Stephanie M. Gogarten
CMCaitlin P. McHugh
Caitlin P. McHugh
CLCathy C. Laurie
Cathy C. Laurie

24 May 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SBSharon R Browning
Sharon R Browning
BBBrian L Browning
Brian L Browning
MDMartha L Daviglus
Martha L Daviglus
RDRamon A Durazo-Arvizu
Ramon A Durazo-Arvizu
NSNeil Schneiderman
Neil Schneiderman
CLCathy C Laurie
Cathy C Laurie
Populations change in size over time due to factors such as population growth, migration, bottleneck events, natural disasters, and disease. The historical effective size of a population affects the power and resolution of genetic association studies. For admixed populations, it is not only the overall effective population size that is of interest, but also the effective sizes of the component ancestral populations. We use identity by descent and local ancestry inferred from genome-wide genetic data to estimate overall and ancestry-specific effective population size during the past hundred generations for nine admixed American populations from the Hispanic Community Health Study/Study of Latinos, and for African-American and European-American populations from two US cities. In these populations, the estimated pre-admixture effective sizes of the ancestral populations vary by sampled population, suggesting that the ancestors of different sampled populations were drawn from different sub-populations. In addition, we estimate that overall effective population sizes dropped substantially in the generations immediately after the commencement of European and African immigration, reaching a minimum around 12 generations ago, but rebounded within a small number of generations afterwards. Of the populations that we considered, the population of individuals originating from Puerto Rico has the smallest bottleneck size of one thousand, while the Pittsburgh African-American population has the largest bottleneck size of two hundred thousand. Using genome-wide genetic data on several hundred individuals sampled from a population, we can estimate the current effective size of the population and the changes in effective size that have occurred over the past hundred generations. Many populations in the Americas are admixed, having ancestry from Europe, Africa, and the Americas. In such cases, one can learn not only about the effective population size history of the admixed population since admixture, but also about the effective population size histories of the contributing ancestral populations. In this paper we develop methodology for estimating past effective population size and analyze data from Hispanic, African-American, and European-American populations resident in the United States. We observe differences between populations in their historical effective sizes. These differences are useful for understanding differences in disease incidence between populations and for identifying populations that will maximize power in genetic association studies.

12 April 2023 in Nature
Verified
Journal Article
Closed access
PDF file
JWJoshua S Weinstock
Joshua S Weinstock
JGJayakrishnan Gopakumar
Jayakrishnan Gopakumar
BBBala Bharathi Burugula
Bala Bharathi Burugula
MUMesbah Uddin
Mesbah Uddin
NJNikolaus Jahn
Nikolaus Jahn
SJSiddhartha Jaiswal
Siddhartha Jaiswal

13 January 2022 in Cell Genomics
Verified
Journal Article
Open access
MTMargaret A. Taub
Margaret A. Taub
MCMatthew P. Conomos
Matthew P. Conomos
RKRebecca Keener
Rebecca Keener
KIKruthika R. Iyer
Kruthika R. Iyer
JWJoshua S. Weinstock
Joshua S. Weinstock
RMRasika A. Mathias
Rasika A. Mathias
Genetic studies on telomere length are important for understanding age-related diseases. Prior GWASs for leukocyte TL have been limited to European and Asian populations. Here, we report the first sequencing-based association study for TL across ancestrally diverse individuals (European, African, Asian, and Hispanic/Latino) from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program. We used whole-genome sequencing (WGS) of whole blood for variant genotype calling and the bioinformatic estimation of telomere length in n = 109,122 individuals. We identified 59 sentinel variants (p < 5 × 10−9) in 36 loci associated with telomere length, including 20 newly associated loci (13 were replicated in external datasets). There was little evidence of effect size heterogeneity across populations. Fine-mapping at OBFC1 indicated that the independent signals colocalized with cell-type-specific eQTLs for OBFC1 (STN1). Using a multi-variant gene-based approach, we identified two genes newly implicated in telomere length, DCLRE1B (SNM1B) and PARN. In PheWAS, we demonstrated that our TL polygenic trait scores (PTSs) were associated with an increased risk of cancer-related phenotypes.